Vext Science, Inc.
VEXTF
$0.095
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.41% | 13.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.41% | 13.43% | |||
| Cost of Revenue | 15.20% | 60.56% | |||
| Gross Profit | 6.68% | -46.18% | |||
| SG&A Expenses | -20.36% | -5.84% | |||
| Depreciation & Amortization | -1.36% | -2.47% | |||
| Other Operating Expenses | -112.27% | -- | |||
| Total Operating Expenses | 1.47% | 30.96% | |||
| Operating Income | 35.81% | -153.03% | |||
| Income Before Tax | 50.57% | -163.03% | |||
| Income Tax Expenses | -111.05% | 945.73% | |||
| Earnings from Continuing Operations | 63.82% | -269.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.82% | -269.07% | |||
| EBIT | 35.81% | -153.03% | |||
| EBITDA | 313.69% | -85.30% | |||
| EPS Basic | 63.71% | -264.71% | |||
| Normalized Basic EPS | 49.46% | -244.44% | |||
| EPS Diluted | 63.71% | -264.71% | |||
| Normalized Diluted EPS | 49.46% | -250.94% | |||
| Average Basic Shares Outstanding | 0.02% | 0.77% | |||
| Average Diluted Shares Outstanding | 0.02% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||